| Overview |
| bsm-63012r |
| USP22 Recombinant Antibody |
| WB, IP, ICC/IF |
| Mouse, Rat |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human USP22 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 23326 |
| Q9UPT9 |
| Ubiquitin carboxyl terminal hydrolase 22; Usp22; USP3L. |
| Deubiquitinase that plays a role in several cellular processes including transcriptional regulation, cell cycle progression or innate immunity. As part of the transcription regulatory histone acetylation (HAT) complex SAGA, catalyzes the deubiquitination of both histones H2A and H2B, thereby acting as a transcriptional coactivator. |
| Application Dilution |
| WB |
1:300-5000 |
| IP |
IFICC1:50-200 |
| ICC/IF |
IP1-2ug |